US 12343357
Compositions and methods for modulating MECP2 expression
granted A61KA61K31/712A61P
Quick answer
US patent 12343357 (Compositions and methods for modulating MECP2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/712, A61P, A61P25/22